Case Study Delivering a Registrational GI Trial Through Ongoing Protocol Shifts An emerging oncology biotech developing next-generation bispecific antibody therapies partnered with Catalyst Oncology to manage Read Now Info Sheet Purpose-Built for ADC Development Antibody-drug conjugates (ADCs) are transforming cancer care by combining precision antibody targeting with potent payloads Read Now Executive Summary Key Takeaways from ADCs in Oncology Trials Webinar This Executive Summary captures the key takeaways from a recent webinar I moderated titled “ADCs Read Now Info Sheet Operationalizing Global Oncology Trials Catalyst Oncology accelerates innovation by aligning strategic insight, deep expertise, a global reach and flawless execution. Read Now Info Sheet Specialized Site Network for Early-phase Oncology Success Early-phase oncology trials are complex, demanding precision, rapid execution, and specialized expertise. Read Now Case Study Accelerating Approval Pathway For Phase III Ovarian Cancer Trial A late-stage biotech was developing a combination therapy for a rare form of ovarian cancer. It is challenging to diagnose, difficult to treat due to its chemo-resistance, and at the time, there were no approved treatments specifically for this indication. Read Now Blog The Resurgence of Antibody-drug Conjugates How ADCs are redefining cancer therapy Cancer treatment is undergoing a transformation, fueled by advances Read Now Case Study Managing a Multiple CRO Relationship Transition A midsized biotech sponsor approached Catalyst Flex with the opportunity to increase biostatistics and data management work from staff augmentation services only to become their preferred biometrics provider. Read Now Blog Precision Medicine The Rise of Targeted Cancer Therapies New cancer cases are expected to increase globally from Read Now Case Study Expanding Relationship from Resourcing to Functional Preferred Provider  A midsized biotech sponsor approached Catalyst Flex with the opportunity to increase biostatistics and data management work from staff augmentation services only to become their preferred biometrics provider. Read Now